tiprankstipranks
Trending News
More News >
Krishna Institute of Medical Sciences Limited (IN:KIMS)
:KIMS
India Market

Krishna Institute of Medical Sciences Limited (KIMS) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Krishna Institute of Medical Sciences Limited has a market cap or net worth of ₹271.99B. The enterprise value is ₹176.63B.
Market Cap₹271.99B
Enterprise Value₹176.63B

Share Statistics

Krishna Institute of Medical Sciences Limited has 400,138,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding400,138,950
Owned by Insiders
Owned by Institutions0.05%

Financial Efficiency

Krishna Institute of Medical Sciences Limited’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 27.44%.
Return on Equity (ROE)0.18
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)27.44%
Return on Capital Employed (ROCE)0.39
Revenue Per Employee
Profits Per Employee
Employee Count
Asset Turnover0.53
Inventory Turnover17.60

Valuation Ratios

The current PE Ratio of Krishna Institute of Medical Sciences Limited is 64.33. Krishna Institute of Medical Sciences Limited’s PEG ratio is -6.72.
PE Ratio64.33
PS Ratio0.00
PB Ratio8.94
Price to Fair Value11.57
Price to FCF-129.54
Price to Operating Cash Flow31.39
PEG Ratio-6.72

Income Statement

In the last 12 months, Krishna Institute of Medical Sciences Limited had revenue of 30.35B and earned 3.85B in profits. Earnings per share was 9.61.
Revenue30.35B
Gross Profit19.09B
Operating Income19.09B
Pretax Income5.58B
Net Income3.85B
EBITDA7.83B
Earnings Per Share (EPS)9.61

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Krishna Institute of Medical Sciences Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.60
52-Week Price Change66.32%
50-Day Moving Average649.47
200-Day Moving Average591.15
Relative Strength Index (RSI)57.59
Average Volume (3m)29.18K

Important Dates

Krishna Institute of Medical Sciences Limited upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 12, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date

Financial Position

Krishna Institute of Medical Sciences Limited as a current ratio of 0.83, with Debt / Equity ratio of 74.13%
Current Ratio0.83
Quick Ratio0.76
Debt to Market Cap0.08
Net Debt to EBITDA3.16
Interest Coverage Ratio21.14

Taxes

In the past 12 months, Krishna Institute of Medical Sciences Limited has paid 1.43B in taxes.
Income Tax1.43B
Effective Tax Rate0.26

Enterprise Valuation

Krishna Institute of Medical Sciences Limited EV to EBITDA ratio is 34.76, with an EV/FCF ratio of -63.71.
EV to Sales8.97
EV to EBITDA34.76
EV to Free Cash Flow-63.71
EV to Operating Cash Flow46.77

Balance Sheet

Krishna Institute of Medical Sciences Limited has ₹1.02B in cash and marketable securities with ₹25.57B in debt, giving a net cash position of ₹24.55B billion.
Cash & Marketable Securities₹1.02B
Total Debt₹25.57B
Net Cash₹24.55B
Net Cash Per Share₹61.35
Tangible Book Value Per Share₹50.30

Margins

Gross margin is 59.34%, with operating margin of 62.89%, and net profit margin of 12.67%.
Gross Margin59.34%
Operating Margin62.89%
Pretax Margin18.39%
Net Profit Margin12.67%
EBITDA Margin25.79%
EBIT Margin19.96%

Analyst Forecast

The average price target for Krishna Institute of Medical Sciences Limited is ₹645.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹645.00
Price Target Upside-1.21% Downside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis